AlphaTON Capital Corp.
ATON • Biotechnology
Extraordinary move
ATON+22.68%
vs. previous close $0.24
$0.29
▲ +0.05 (+22.68%)
Current price
EarningsLatest report: Mar 31, 2026
WEAK PROFILEWeakConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Weak historical ratio profile. The current evidence does not support a favorable risk/reward view.
Market Cap
$666,633
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0.02Weak liquidity · 0.31Weak profitability
Financial data as of: Mar 31, 2026, 12:00 AM UTCLast earnings update: Mar 31, 2026, 12:00 AM UTCLast profile update: Aug 7, 2026, 1:48 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$0.29
Change22.68%
Market Cap$666.63K
52W Range0.18 - 13.80
Beta0.49
Gross Margin100.00%
Oper. Margin-238.10%
Profit Margin-398.21%
Debt/Eq0.02
Current Ratio0.31
Quick Ratio0.31
Target$4.88
Price$0.29
Change22.68%
Market Cap$666.63K
52W Range0.18 - 13.80
Beta0.49
Gross Margin100.00%
Oper. Margin-238.10%
Profit Margin-398.21%
Debt/Eq0.02
Current Ratio0.31
Quick Ratio0.31
Target$4.88
Target Upside1567.81%
Target Median$4.88
Target Range4.50 - 5.25
Volume13.97M
Avg Volume5.24M
EPS Surprise-3.78
Investment DNA
How strong this company looks for long-term investors
36
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
39/100
Growth Potential
Revenue and expansion
50/100
Price Attractiveness
Cheap or expensive today
58/100
Why this score▼
Manageable debt level · 0.02Weak liquidity · 0.31Weak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
No vote count available
Bullish
0
Hold
0
Bearish
0
Price Target
2026-08-07
Low
$4.50
Mean
$4.88
Median
$4.88
High
$5.25
🧾
No insider activity
No recent insider transactions available.